Journal of Opioid Management

08/22/2025

⏳ Final 2 Weeks: Earn 9.25 CME/CPE Credits -Advance your knowledge of buprenorphine
+ Get a FREE Bonus: 1-year subscription to Journal of Opioid Management (Over $400 in Bonus Value*)!

REGISTER NOW: https://bit.ly/4mwBkgQ

There are just over TWO weeks left to access the BUPE2024/2025 virtual learning site—your opportunity to gain up to 9.25 AMA PRA Category 1 Credits™ or CPE credits in buprenorphine education. There are 14 excellent presentations designed for quick learning and retention. Here are a few:

Buprenorphine: Not Just Another Opioid – Understanding the World’s Most Interesting Opioid

Impact of an Education Module on the Knowledge and Attitudes of EM Physicians Towards Prescribing Buprenorphine / Naloxone for Opioid Use Disorder

Buprenorphine: Opioid Agonist-Antagonist Benefits for Opioid Resistant Pain Uncontrolled By Full-Agonist Opioids during Hematopoietic Stem Cell Transplant for Sickle Cell Disease

Conversion of CII Opioid Medications to Buprenorphine in the Chronic Pain Population – Insights and Clinical Pearls

Clinical Pharmacist with DEA License: Efforts to Increase Access to Buprenorphine in a Veteran Population

Outpatient Cross-Titration to Buprenorphine for Chronic Pain

The “Micro”cosm: Magnifying the Nuance of Low Dose Buprenorphine Inductions

REGISTER NOW TO WATCH THESE PRESENTATIONS + 7 more: https://bit.ly/4mwBkgQ
Whether you’ve started or haven’t registered yet, now is the time to act. *Get your learning and post-test completed before August 31 to earn your credits and claim your bonus! The website will stay live through at least the end of 2025 so you can return to refresh your learning at any time. You just need to claim your CME credit by August 31, 2025.

Don't miss this opportunity for convenient learning and CME/CPE credits!

08/15/2025

BUPRENORPHINE EDUCATION
⏳ Final 3 Weeks: Earn 9.25 CME/CPE Credits + Get Over $400 in Bonus Value!

Time is running out! There are just THREE weeks left to access the BUPE2024/2025 virtual learning site—your opportunity to gain up to 9.25 AMA PRA Category 1 Credits™ or CPE credits in BUPRENORPHINE education. Whether you’ve started or haven’t registered yet, now is the time to act. Get your learning and post-test completed before August 31 to earn your credits and claim your bonus! The website will stay live through at least the end of 2025 so you can return to refresh your learning at any time. You just need to claim your CME/CPE credit by August 31, 2025. www.bupe2024.com

BUPE2024/2025 features an expert-led lineup of clinical video modules focused on buprenorphine, a medication that remains misunderstood and underutilized despite its proven value in treating opioid use disorder and pain. Learn about office-based induction, best practices for chronic pain, patient case studies, co-management strategies, and more—delivered by respected leaders in addiction medicine, pain management, and primary care. www.bupe2024.com

NOTE: This is a self-funded educational program by the Journal of Opioid Management.

To wrap up this landmark educational initiative, we’re also offering a one-year online subscription to the Journal of Opioid Management (a value of over $400) with every paid registration of just $299. But don’t wait—you must complete your post-test by August 31, 2025, to qualify for both your credits and your bonus subscription.

Register or log in now: www.bupe2024.com

Learn more about Buprenorphine and its use in pain and substance use disorders. Share in the latest research and clinical experience! Cutting-edge information on Buprenorphine and its use in medicine. BUPE2024/2025: Buprenorphine in Medicine is a “virtual conference/resource” for those looking t...

08/11/2025

BUPRENORPHINE EDUCATION
⏳ Final 3 Weeks: Earn 9.25 CME/CPE Credits + Get Over $400 in Bonus Value!

Time is running out! There are just THREE weeks left to access the BUPE2024/2025 virtual learning site—your opportunity to gain up to 9.25 AMA PRA Category 1 Credits™ or CPE credits in BUPRENORPHINE education. Whether you’ve started or haven’t registered yet, now is the time to act. Get your learning and post-test completed before August 31 to earn your credits and claim your bonus! The website will stay live through at least the end of 2025 so you can return to refresh your learning at any time. You just need to claim your CME/CPE credit by August 31, 2025. www.bupe2024.com

BUPE2024/2025 features an expert-led lineup of clinical video modules focused on buprenorphine, a medication that remains misunderstood and underutilized despite its proven value in treating opioid use disorder and pain. Learn about office-based induction, best practices for chronic pain, patient case studies, co-management strategies, and more—delivered by respected leaders in addiction medicine, pain management, and primary care. www.bupe2024.com

NOTE: This is a self-funded educational program by the Journal of Opioid Management.

To wrap up this landmark educational initiative, we’re also offering a one-year online subscription to the Journal of Opioid Management (a value of over $400) with every paid registration of just $299. But don’t wait—you must complete your post-test by August 31, 2025, to qualify for both your credits and your bonus subscription.

Register or log in now: www.bupe2024.com

08/11/2025

https://conta.cc/4mfNjz2

Time is running out! There are just over THREE weeks left to access the BUPE2024/2025 virtual learning site—your opportunity to gain up to 9.25 AMA PRA Category 1 Credits™ or CPE credits in buprenorphine education. Whether you’ve started or haven’t registered yet, now is the time to act. Get...

08/01/2025

BUPRENORPHINE EDUCATION
⏳ Final 5 Weeks: Earn 9.25 CME/CPE Credits + Get Over $400 in Bonus Value!

Time is running out! There are just FIVE weeks left to access the BUPE2024/2025 virtual learning site—your opportunity to gain up to 9.25 AMA PRA Category 1 Credits™ or CPE credits in BUPRENORPHINE education. Whether you’ve started or haven’t registered yet, now is the time to act. Get your learning and post-test completed before August 31 to earn your credits and claim your bonus! The website will stay live through at least the end of 2025 so you can return to refresh your learning at any time. You just need to claim your CME/CPE credit by August 31, 2025. www.bupe2024.com

BUPE2024/2025 features an expert-led lineup of clinical video modules focused on buprenorphine, a medication that remains misunderstood and underutilized despite its proven value in treating opioid use disorder and pain. Learn about office-based induction, best practices for chronic pain, patient case studies, co-management strategies, and more—delivered by respected leaders in addiction medicine, pain management, and primary care. www.bupe2024.com

To wrap up this landmark educational initiative, we’re also offering a one-year online subscription to the Journal of Opioid Management (a value of over $400) with every paid registration of just $299. But don’t wait—you must complete your post-test by August 31, 2025, to qualify for both your credits and your bonus subscription.

Register or log in now: www.bupe2024.com

Learn more about Buprenorphine and its use in pain and substance use disorders. Share in the latest research and clinical experience! Cutting-edge information on Buprenorphine and its use in medicine. BUPE2024/2025: Buprenorphine in Medicine is a “virtual conference/resource” for those looking t...

06/26/2025

Final Call for Papers, Research, Case Studies, Literature Reviews and Expert Analysis

Journal of Opioid Management: What is the future of opioids?

The Journal of Opioid Management invites submissions for a special issue exploring the future of opioids from diverse perspectives.

In light of the evolving landscape of opioid use and management, we seek contributions that offer insights into the trajectory of opioid-related research, clinical practice, and public health strategies over the next 2-5 years. Authors are encouraged to examine the past and present paradigms of opioid use, incorporating insights from current clinical trials and advancements in opioid pharmacology, to provide forward-looking perspectives on the future of opioids.

Deadline for submissions: June 30th, 2025

Submit your article here: https://wmpllc.org/ojs/index.php/jom/manuscriptsubmission

To go directly to the manuscript portal, click here: https://www.editorialmanager.com/JOM/default.aspx . Click on "New users should register for a new account". After you register you will be able to click on a link to submit a manuscript, this will forward you to a page with instructions.